Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > Meeting highlights from thePharmacovigilance Risk AssessmentCommittee (PRAC) 7-10 June 2022
Meeting-highlights-from-the-Pharmacovigilance-Risk-Assessment-Committee-PRAC-7-10-June-2022-_-European-Medicines-Agency-1Télécharger
Marie Berger 4 July 2022 All news
  • ← Key performance indicators (KPIs) to monitor the European clinical trials environment
  • Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 July 2022 →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • European contact points for clinical trials
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023
  • Clinical Trials Regulation (EU) No 536/2014 in practice
Copyright © 2018 - Pharmya - Legal terms - Quality Policy